Andlauer Healthcare Group (TSE:AND – Get Free Report) had its price objective lowered by Scotiabank from C$47.50 to C$46.00 in a report released on Monday, BayStreet.CA reports. The firm currently has an “outperform” rating on the stock. Scotiabank’s target price indicates a potential upside of 13.36% from the company’s current price.
Several other equities analysts have also recently issued reports on AND. National Bankshares lifted their price objective on Andlauer Healthcare Group from C$46.00 to C$47.00 and gave the stock a “sector perform” rating in a report on Thursday, March 7th. Stifel Nicolaus decreased their price objective on shares of Andlauer Healthcare Group from C$55.00 to C$52.00 and set a “buy” rating on the stock in a research report on Monday. CIBC cut their target price on shares of Andlauer Healthcare Group from C$52.00 to C$50.00 and set an “outperform” rating for the company in a research report on Monday. Royal Bank of Canada lowered their price target on shares of Andlauer Healthcare Group from C$43.00 to C$41.00 and set a “sector perform” rating on the stock in a research report on Monday. Finally, Eight Capital cut their price objective on Andlauer Healthcare Group from C$62.00 to C$58.00 and set a “buy” rating for the company in a research report on Thursday, March 7th. Two investment analysts have rated the stock with a hold rating and five have issued a buy rating to the company. According to data from MarketBeat.com, Andlauer Healthcare Group currently has a consensus rating of “Moderate Buy” and a consensus target price of C$49.43.
Check Out Our Latest Stock Report on AND
Andlauer Healthcare Group Trading Up 0.7 %
Andlauer Healthcare Group (TSE:AND – Get Free Report) last released its quarterly earnings data on Tuesday, March 5th. The company reported C$0.44 EPS for the quarter, missing analysts’ consensus estimates of C$0.49 by C($0.05). Andlauer Healthcare Group had a return on equity of 14.53% and a net margin of 10.21%. The company had revenue of C$169.07 million for the quarter, compared to analysts’ expectations of C$165.00 million. As a group, sell-side analysts anticipate that Andlauer Healthcare Group will post 1.8439434 earnings per share for the current fiscal year.
About Andlauer Healthcare Group
Andlauer Healthcare Group Inc, a supply chain management company, provides a platform of customized third-party logistics (3PL) and specialized transportation solutions for the healthcare sector in Canada and the United States. The company operates in two segments, Specialized Transportation and Healthcare Logistics.
Recommended Stories
- Five stocks we like better than Andlauer Healthcare Group
- Investing In Preferred Stock vs. Common Stock
- Garmin Navigates to New Highs Driven By Wearables Trend
- What is a SEC Filing?
- Pinterest Prospers From AI Boosting Shop-Ability and Relevance
- Stock Average Calculator
- AbbVie Tracking for New Highs in 2024
Receive News & Ratings for Andlauer Healthcare Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Andlauer Healthcare Group and related companies with MarketBeat.com's FREE daily email newsletter.